Ventyx Biosciences, Inc. (VTYX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Ventyx Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Ventyx Biosciences, Inc. (VTYX) has returned 55.04% so far this year and 1,117.39% over the past 12 months.

Based on dividend-adjusted daily data since Oct 21, 2021, VTYX's average daily return is +0.25%, while the average monthly return is +7.58%. At this rate, your investment would double in approximately 0.8 years.

Historically, 52% of months were positive and 48% were negative. The best month was Feb 2024 with a return of +235.6%, while the worst month was Nov 2023 at -85.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, VTYX closed higher 47% of trading days. The best single day was Oct 23, 2025 with a return of +71.0%, while the worst single day was Nov 7, 2023 at -80.6%.

Ventyx Biosciences, Inc. has an annualized alpha of 61.56%, beta of 1.44, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since October 22, 2021.

• This stock participated in 188.44% of S&P 500 Index downside but only 137.30% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

VTYX ranks 99 for risk / return — in the top 99% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Ventyx Biosciences, Inc. (VTYX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ventyx Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ventyx Biosciences, Inc. was 98.21%, occurring on Apr 7, 2025. The portfolio has not yet recovered.

The current Ventyx Biosciences, Inc. drawdown is 69.99%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Ventyx Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Ventyx Biosciences, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.